Alexandra was President and Chief Executive Officer at Sensorium Therapeutics, and Independent Board Member at Scenic Biotech. Alexandra Glucksmann joined Sensorium Therapeutics in 2024.
Alexandra Glucksmann is currently
Create your alert
to follow the career of Alexandra Glucksmann.
Alexandra Glucksmann has a PhD in Molecular Genetics and Cell Biology from University of Chicago and a Post-Doctoral in Molecular Biology from Massachusetts Institute of TechnologyMassachusetts Institute of Technology.
They have also studied at University of Chicago :
Find more alumni from University of Chicago
Do you need to know more about Alexandra Glucksmann? More results.
Report an error
Update the org chart details of Alexandra Glucksmann.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.